Literature DB >> 23886710

miR-145 suppresses osteogenic differentiation by targeting Sp7.

Jie Jia1, Qing Tian, Song Ling, Yong Liu, Shuhua Yang, Zengwu Shao.   

Abstract

Osteogenesis depends on a coordinated network of transcription factors including Sp7. Emerging evidence indicates that microRNAs (miRNAs) act as pivotal regulators in various biological processes including osteoblast proliferation and differentiation. Here, we investigated the effect of miR-145 on osteogenic differentiation. miR-145 was decreased during osteogenic differentiation, which could suppress the osteogenic differentiation of C2C12 and MC3T3-E1 cells confirmed by gain- and loss-of-function experiments. Moreover, bioinformatic analysis combined with luciferase reporter assay, and Western blot validated that miR-145 negatively regulated Sp7 expression. Inhibition of Sp7 showed similar effect with miR-145 on osteogenic differentiation, whereas overexpression of Sp7 attenuated this effect. Collectively, these data indicate that miR-145 is a novel regulator of Sp7, and it suppresses the osteogenic differentiation of C2C12 and MC3T3-E1 cells.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Differentiation; Osteogenesis; Sp7; miR-145

Mesh:

Substances:

Year:  2013        PMID: 23886710     DOI: 10.1016/j.febslet.2013.07.030

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  36 in total

Review 1.  Mediators of inflammation and bone remodeling in rheumatic disease.

Authors:  Anita T Shaw; Ellen M Gravallese
Journal:  Semin Cell Dev Biol       Date:  2015-10-19       Impact factor: 7.727

2.  MicroRNA profiling of antler stem cells in potentiated and dormant states and their potential roles in antler regeneration.

Authors:  Hengxing Ba; Datao Wang; Chunyi Li
Journal:  Mol Genet Genomics       Date:  2016-01-06       Impact factor: 3.291

Review 3.  Epigenetic pathways regulating bone homeostasis: potential targeting for intervention of skeletal disorders.

Authors:  Jonathan A R Gordon; Martin A Montecino; Rami I Aqeilan; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Curr Osteoporos Rep       Date:  2014-12       Impact factor: 5.096

4.  Integrated miRNA and mRNA expression profiling of tension force-induced bone formation in periodontal ligament cells.

Authors:  Maolin Chang; Heng Lin; Meng Luo; Jie Wang; Guangli Han
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-06-20       Impact factor: 2.416

5.  BMP9-induced osteogenic differentiation is partially inhibited by miR-30a in the mesenchymal stem cell line C3H10T1/2.

Authors:  Ruyi Zhang; Yaguang Weng; Baolin Li; Yingjiu Jiang; Shujuan Yan; Fang He; Xiaoqing Chen; Fang Deng; Jing Wang; Qiong Shi
Journal:  J Mol Histol       Date:  2015-07-24       Impact factor: 2.611

6.  Expression of Sp7 in Satb2-induced osteogenic differentiation of mouse bone marrow stromal cells is regulated by microRNA-27a.

Authors:  Yiming Gong; Jing Lu; Xiaoping Yu; Youcheng Yu
Journal:  Mol Cell Biochem       Date:  2016-05-03       Impact factor: 3.396

7.  MiR-5100 promotes osteogenic differentiation by targeting Tob2.

Authors:  Huaxin Wang; Yazhou Cui; Jing Luan; Xiaoyan Zhou; Chengzhi Li; Haiying Li; Liang Shi; Jinxiang Han
Journal:  J Bone Miner Metab       Date:  2016-11-21       Impact factor: 2.626

8.  miRNA-145 is associated with spontaneous hypertension by targeting SLC7A1.

Authors:  Yong Wang; Liyan Jin
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

9.  MiR-21 overexpression improves osteoporosis by targeting RECK.

Authors:  Weigong Zhao; Yanying Dong; Caijun Wu; Yunfeng Ma; Yaofeng Jin; Yanhong Ji
Journal:  Mol Cell Biochem       Date:  2015-04-17       Impact factor: 3.396

10.  miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.

Authors:  Lei Shi; Zhimin Wang; Guan Sun; Yi Wan; Jun Guo; Xingli Fu
Journal:  Neuromolecular Med       Date:  2014-04-29       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.